Fraxiforte 0.6 mL

Fraxiforte 0.6 mL is a medicine authorised by Swissmedic under authorisation number 54499. The authorisation holder is Viatris Pharma GmbH. The medicinal product code is Biotechnological medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 10 February 1998 and the authorisation is valid without a time limit. ATC code B01AB06 places the medicine in the group Antithrombotic agents.

  • Dispensing category B
  • Authorisation number 54499
  • ATC B01AB06
  • Biotechnological medicines
Authorisation data
Authorisation number54499
NameFraxiforte 0.6 mL
Full nameFraxiforte 0.6 mL, Injektionslösung in einer Fertigspritze
Authorisation holderViatris Pharma GmbH
Medicinal product codeBiotechnological medicines
Dispensing categoryB · Prescription only
ATC codeB01AB06
First authorisation10 February 1998
Authorisation validityunlimited
Strengths
No.NameDispensing categoryAuthorisation date
1Fraxiforte 0.6 mL, Injektionslösung in einer FertigspritzeB10 February 1998
2Fraxiforte 0.8 mL, Injektionslösung in einer FertigspritzeB10 February 1998
3Fraxiforte 1 mL, Injektionslösung in einer FertigspritzeB10 February 1998

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
1910Spritze(n)B01AB0606.03.3.B
432Spritze(n)B01AB0606.03.3.B
2710Spritze(n)B01AB0606.03.3.B
782Spritze(n)B01AB0606.03.3.B
3510Spritze(n)B01AB0606.03.3.B
942Spritze(n)B01AB0606.03.3.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Fraxiforte 0.6 mL authorised in Switzerland?

Yes. Fraxiforte 0.6 mL is authorised by Swissmedic under authorisation number 54499, data as of 01 September 2026. The authorisation is valid without a time limit.

Which dispensing category does Fraxiforte 0.6 mL have?

Fraxiforte 0.6 mL is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Fraxiforte 0.6 mL?

The authorisation holder is Viatris Pharma GmbH. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com